AMAN compared with GUTS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMANAmanat Acquisition Corp.

Mkt capRevenueRevenue

GUTSFractyl Health, Inc.

Mkt capRevenueRevenue

Compare

AMANAmanat Acquisition Corp.

GUTSFractyl Health, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMANAmanat Acquisition Corp.

10.20▲+0.49%· post 10.13

Mkt cap$54.4MRevenue—Revenue—

GUTSFractyl Health, Inc.

0.98▼−0.73%· post 0.97

ClosedOct 30 '26

Mkt cap$13.0MRevenue$3,000Q4 FY24Revenue$93,000FY24

Compare

ClosedOct 30 '26

AMANAmanat Acquisition Corp.

GUTSFractyl Health, Inc.

10.20▲+0.49%post 10.13

Price

0.98▼−0.73%post 0.97

$54.4M

Mkt cap

$13.0M

—

Revenue

$3,000Q4 FY24

—

Revenue

$93,000FY24

AMAN10.20▲+0.49%vsGUTS0.98▼−0.73%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

AMAN, solidGUTS, dashed

Supply-chain overlap

Revenue flow

AMAN: latest quarter not drawable. GUTS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMAN 0

None

Shared 0

No disclosed counterparties: AMAN.

Only GUTS 1

—Everself (formerly Bariendo)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR